In patients with advanced colorectal cancer patients treated with different FOLFOX regimens those with diabetes were maintained on required doses of insulin during the course of treatment but the extent of insulin adjustment during treatment was not specified [39]. The gene discussed is INS; the disease is diabetes mellitus.